CLOPITAB A 75MG CAP
₹121.25
CLOPITAB A 75MG CAP is a combination capsule containing Clopidogrel 75 mg and Aspirin, used to reduce the risk of blood clots, heart attacks, and strokes by dual inhibition of platelet aggregation in cardiovascular patients.
Description
CLOPITAB A 75MG CAP combines Clopidogrel 75 mg and low-dose Aspirin to provide effective dual antiplatelet therapy. Clopidogrel blocks the ADP receptors on platelets, preventing them from clumping together, while Aspirin inhibits the cyclooxygenase (COX) enzyme, reducing the formation of thromboxane A2, a key factor in platelet activation.
This combination is prescribed for patients with acute coronary syndrome, recent myocardial infarction, ischemic stroke, or those undergoing coronary artery stenting. The dual mechanism of action helps prevent harmful blood clots, thereby lowering the risk of serious cardiovascular events.
Patients must take CLOPITAB A 75MG CAP exactly as prescribed and should be monitored for signs of bleeding or other side effects due to increased bleeding risk associated with combined antiplatelet therapy.
Reviews
There are no reviews yet.